about
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimenMTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancerFunctional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Novel G protein-coupled responses in leukocytes elicited by a chemotactic bacteriophage displaying a cell type-selective binding peptide.Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display.Direct fluorochrome labeling of phage display library clones for studying binding specificities: applications in flow cytometry and fluorescence microscopy.Rational identification of a novel peptide for targeting nanocarriers to 9L glioma.Selective targeting of nanocarriers to neutrophils and monocytes.DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.Examining racial differences in diffuse large B-cell lymphoma presentation and survival.Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityChronic GvHD decreases antiviral immune responses in allogeneic BMT.DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activationTranslational applications of flow cytometry in clinical practice.Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharide.PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipientsPurification and identification of cell surface antigens using lamprey monoclonal antibodies.Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival.Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody).Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development.Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivationOligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case ReportMultiple myeloma immunoglobulin lambda translocations portend poor prognosisHistologic examination of bone marrow core biopsy specimens has limited value in the diagnosis of mycobacterial and fungal infections in patients with the acquired immunodeficiency syndromeExpression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasmsRecovery and rebound of platelet counts in mice after thrombocytopenia induced by combination bortezomib + romidepsinRapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytesCharacteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phaseThe role of CD11c expression in the diagnosis of mantle cell lymphomaRituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphomaIs a 500-Cell Count Necessary for Bone Marrow Differentials?: A Proposed Analytical Method for Validating a Lower CutoffFlt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation OutcomesMachine-based detection and classification for bone marrow aspirate differential counts: initial development focusing on nonneoplastic cells
P50
Q24305562-A789FEE1-27B3-47E2-8042-5A1487C29B8BQ24658236-BCF5D939-8055-4906-BFA1-1E019CB1FFA3Q28198153-799BC270-89EB-46A5-A01D-9CDDE743D318Q30490975-1EDD5797-4E63-48B1-A376-008F7B43BB9AQ30991301-2DFF821E-AF86-4DBB-94D0-73AA0EFABB9DQ31139868-2DE9A104-75A6-44B4-8B51-D9308B8ABFEAQ33210500-B83BE80F-DE0C-457B-8AD1-EB2C2974F47AQ33315122-1B6F3A7E-F7A7-4D92-9BC0-356C92460847Q33433964-9C2B023D-AFDC-4146-8A9E-1BB396BC76CDQ34096524-757984F4-E933-4F4C-B443-9209D3DDA9BEQ34117972-CA1720ED-C0EF-42AF-8449-ABF6CC9CB270Q35691842-89B1DCF6-63AB-4C32-BE17-2F6C5D220E8DQ35828696-759953B2-BE35-4E72-90A3-1647AF43998FQ37358008-5DAF0CA2-00D3-45E6-9414-7D5282D2158AQ38007401-3C18B8D3-2D9E-4561-849F-AA01AB6877DAQ38153477-6B03F6E3-9940-4723-A2B8-B0969A57863BQ38243214-2E7E4A28-34C5-46A6-B269-F05DEB2FBA48Q40640093-7F0B16C3-09B4-411F-80BF-307DE8C22839Q41345224-1B346300-F457-417D-8556-97BB85D5A599Q41759464-2BAAAA93-623E-40BF-9389-F4E39C6705A7Q42365163-42D7C827-34F0-43FF-88AA-98660BACA448Q42575861-CCAAD217-C178-4581-A6D2-F81E55374CEDQ48148612-0F0CE34F-A920-4DAA-9060-D9B15FEDDC9AQ48661760-5BA2B1A8-0254-45AA-9BBC-54AC1AADACEDQ51800094-04AF3756-FD4E-4EE6-8F54-72B46677E754Q52723665-2ED17C7E-4E4F-4181-A02B-16E33FF4AF2AQ53354519-DBFE372A-D740-4276-86A5-A63D3B520850Q58471880-1C98A272-DEB5-42C2-A8CD-BCB05E504288Q60947916-E1975B57-8671-4BDD-9E8D-A1A311745F85Q64097718-CC16F48A-F201-4429-A3B1-853EE91E17AEQ73468666-8E74DAF0-2339-4806-ACF6-2AA2C70A0126Q80336570-F96509B1-0E05-4321-A449-E3FA5B8F3794Q82599255-3487BC15-716B-4149-A296-0798E1EEAD18Q82617597-E072E232-D335-4D34-BD4B-08E34540AC7AQ84513629-792576DC-7262-4BF3-823F-68F39468EB18Q84595705-E550EEEE-3F7C-4256-B9FA-AF0636459090Q84881857-192A0387-1676-4C5B-A5AE-22B34876369FQ88661493-718555F0-2F30-43C6-BED5-0DDDE9F36F00Q90022516-B85AC7FE-43CA-48A8-87D2-33AA4D62FF79Q90390510-F12A6F53-686D-4695-AA76-D971D8D733F2
P50
description
researcher
@en
name
David L Jaye
@en
David L Jaye
@nl
type
label
David L Jaye
@en
David L Jaye
@nl
prefLabel
David L Jaye
@en
David L Jaye
@nl
P106
P31
P496
0000-0001-7977-6909